Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Sutton calls for Wiggins, Freeman to 'tell the truth'

Published 03/07/2018, 03:07 AM
Updated 03/07/2018, 03:07 AM
© Reuters. 2016 Rio Olympics - Cycling Track - Men's Team Pursuit Final Gold Race

© Reuters. 2016 Rio Olympics - Cycling Track - Men's Team Pursuit Final Gold Race

(Reuters) - Britain's first Tour de France winner Bradley Wiggins and former Team Sky doctor Richard Freeman need to come forward and give a full explanation of how they used asthma drugs, according to the team's ex-coach Shane Sutton.

The UK government's Digital, Culture, Media and Sport (DCMS) select committee released a report this week saying the team had crossed an "ethical line" by using performance-enhancing drugs that are allowed for medical purposes.

Wiggins, also a five-time Olympic gold medalist, told the BBC on Monday that he had "100 percent" not cheated but Sutton believes a more detailed response was needed.

"They need to explain it all to everybody," the Australian, who had a key coaching role at Team Sky from 2010-13, told Sky Sports.

Wiggins was granted a therapeutic use exemption (TUE) to take the corticosteroid Triamcinolone, which helps asthma sufferers, shortly before the 2011 Tour de France, his 2012 Tour win and the 2013 Giro d'Italia.

But the report, that received "confidential material from a well-placed and respected source" about Sky's medical policy from 2011-13, believes the 37-year-old may have been treated with Triamcinolone on up to nine occasions over four years.

Sutton wants Wiggins and Freeman to come forward and clear up the inconsistencies between what the DCMS committee heard about the frequency of the cyclist's use of the drug, compared to what the rider said himself on Monday.

"I cannot say I know a lot about Brad's use of it in or out of competition," Sutton, who gave evidence to the committee last year, said.

"I am told by the doctor he needs a TUE for this event etcetera etcetera. Outside of the event, you have to sit down and ask them. I am calling for him and the doctor to come forward and tell the truth.

"He is a sufferer, I have seen him suffer and gasping for breath after effort, I saw what he was going through, I cannot answer how often he used it. Only the doctor and him can tell us."

© Reuters. 2016 Rio Olympics - Cycling Track - Men's Team Pursuit Final Gold Race

(This version of the story has been refiled to fix typo in lead)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.